• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD44+ 和 CD133+ 非小细胞肺癌细胞表现出与 p53 状态相关的 DNA 损伤反应途径和休眠多倍体巨癌细胞富集。

CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.

机构信息

School of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141700 Dolgoprudny, Russia.

State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency (SRC-FMBC), 123098 Moscow, Russia.

出版信息

Int J Mol Sci. 2022 Apr 28;23(9):4922. doi: 10.3390/ijms23094922.

DOI:10.3390/ijms23094922
PMID:35563313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9101266/
Abstract

Cancer stem cells (CSCs) play a critical role in the initiation, progression and therapy relapse of many cancers including non-small cell lung cancer (NSCLC). Here, we aimed to address the question of whether the FACS-sorted CSC-like (CD44 + &CD133 +) vs. non-CSC (CD44-/CD133- isogenic subpopulations of p53wt A549 and p53null H1299 cells differ in terms of DNA-damage signaling and the appearance of "dormant" features, including polyploidy, which are early markers (predictors) of their sensitivity to genotoxic stress. X-ray irradiation (IR) at 5 Gy provoked significantly higher levels of the ATR-Chk1/Chk2-pathway activity in CD44-/CD133- and CD133+ subpopulations of H1299 cells compared to the respective subpopulations of A549 cells, which only excited ATR-Chk2 activation as demonstrated by the Multiplex DNA-Damage/Genotoxicity profiling. The CD44+ subpopulations did not demonstrate IR-induced activation of ATR, while significantly augmenting only Chk2 and Chk1/2 in the A549- and H1299-derived cells, respectively. Compared to the A549 cells, all the subpopulations of H1299 cells established an increased IR-induced expression of the γH2AX DNA-repair protein. The CD44-/CD133- and CD133+ subpopulations of the A549 cells revealed IR-induced activation of ATR-p53-p21 cell dormancy signaling-mediated pathway, while none of the CD44+ subpopulations of either cell line possessed any signs of such activity. Our data indicated, for the first time, the transcription factor MITF-FAM3C axis operative in p53-deficient H1299 cells, specifically their CD44+ and CD133+ populations, in response to IR, which warrants further investigation. The p21-mediated quiescence is likely the predominant surviving pathway in CD44-/CD133- and CD133+ populations of A549 cells as indicated by single-cell high-content imaging and analysis of Ki67- and EdU-coupled fluorescence after IR stress. SA-beta-galhistology revealed that cellular-stress-induced premature senescence (SIPS) likely has a significant influence on the temporary dormant state of H1299 cells. For the first time, we demonstrated polyploid giant and/or multinucleated cancer-cell (PGCC/MGCC) fractions mainly featuring the progressively augmenting Ki67 phenotype in CD44+ and CD133+ A549 cells at 24-48 h after IR. In contrast, the Ki67 phenotype enrichment in the same fractions of all the sorted H1299 cells suggested an increase in their cycling/heterochromatin reorganization activity after IR stress. Our results proposed that entering the "quiescence" state rather than p21-mediated SIPS may play a significant role in the survival of p53wt CSC-like NSCLC cells after IR. The results obtained are important for the selection of therapeutic schemes for the treatment of patients with NSCLC, depending on the functioning of the p53 system in tumor cells.

摘要

癌症干细胞 (CSCs) 在许多癌症的发生、进展和治疗复发中起着关键作用,包括非小细胞肺癌 (NSCLC)。在这里,我们旨在解决以下问题:p53wt A549 和 p53null H1299 细胞的 FACS 分选的 CSC 样(CD44 + 和 CD133 +)与非 CSC(CD44-/CD133-)同基因亚群在 DNA 损伤信号转导和“休眠”特征(包括多倍体,这是其对遗传毒性应激敏感性的早期标志物(预测因子))方面是否存在差异。X 射线照射 (IR) 5Gy 可显著增加 H1299 细胞的 CD44-/CD133- 和 CD133+ 亚群中 ATR-Chk1/Chk2 通路的活性,而 A549 细胞的相应亚群仅激活 ATR-Chk2 激活,如 Multiplex DNA-Damage/Genotoxicity profiling 所示。CD44+ 亚群未表现出 IR 诱导的 ATR 激活,而仅在 A549 和 H1299 衍生细胞中分别显著增加 Chk2 和 Chk1/2。与 A549 细胞相比,H1299 细胞的所有亚群均建立了增加的 IR 诱导的 γH2AX DNA 修复蛋白表达。A549 细胞的 CD44-/CD133- 和 CD133+ 亚群显示出 IR 诱导的 ATR-p53-p21 细胞休眠信号转导介导的途径的激活,而两种细胞系的任何 CD44+ 亚群均未显示出任何此类活性的迹象。我们的数据首次表明,在 p53 缺陷型 H1299 细胞中,特别是在其 CD44+和 CD133+ 群体中,存在转录因子 MITF-FAM3C 轴在 IR 下的作用,这值得进一步研究。p21 介导的静止很可能是 A549 细胞的 CD44-/CD133- 和 CD133+ 群体中的主要存活途径,如 IR 应激后单细胞高内涵成像和 Ki67-和 EdU 偶联荧光分析所示。SA-β-半乳糖组织化学显示,细胞应激诱导的过早衰老 (SIPS) 可能对 H1299 细胞的暂时休眠状态有重大影响。我们首次证明了多倍体巨细胞和/或多核癌细胞 (PGCC/MGCC) 亚群,其特征主要是在 IR 后 24-48 小时,在 CD44+和 CD133+ A549 细胞中 Ki67 表型逐渐增加。相比之下,在所有分选的 H1299 细胞的相同亚群中 Ki67 表型的富集表明在 IR 应激后它们的循环/异染色质重排活性增加。我们的结果表明,进入“静止”状态而不是 p21 介导的 SIPS 可能在 p53wt CSC 样 NSCLC 细胞在 IR 后存活中起重要作用。这些结果对于根据肿瘤细胞中 p53 系统的功能选择治疗 NSCLC 患者的治疗方案非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/6a94705c9bdf/ijms-23-04922-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/f45ead5216a8/ijms-23-04922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/836e81b40191/ijms-23-04922-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/7afed0b24b43/ijms-23-04922-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/a8e995075142/ijms-23-04922-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/8b031d0f83db/ijms-23-04922-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/aa3c31fe1677/ijms-23-04922-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/b13a9f701147/ijms-23-04922-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/c01efbd9ad22/ijms-23-04922-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/54dcb314c4a2/ijms-23-04922-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/6a94705c9bdf/ijms-23-04922-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/f45ead5216a8/ijms-23-04922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/836e81b40191/ijms-23-04922-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/7afed0b24b43/ijms-23-04922-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/a8e995075142/ijms-23-04922-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/8b031d0f83db/ijms-23-04922-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/aa3c31fe1677/ijms-23-04922-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/b13a9f701147/ijms-23-04922-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/c01efbd9ad22/ijms-23-04922-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/54dcb314c4a2/ijms-23-04922-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7911/9101266/6a94705c9bdf/ijms-23-04922-g010.jpg

相似文献

1
CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.CD44+ 和 CD133+ 非小细胞肺癌细胞表现出与 p53 状态相关的 DNA 损伤反应途径和休眠多倍体巨癌细胞富集。
Int J Mol Sci. 2022 Apr 28;23(9):4922. doi: 10.3390/ijms23094922.
2
The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.多分割照射存活 NSCLC 细胞的 CD44high 亚群根据其 p53 状态表现出部分 EMT 程序激活和 DNA 损伤反应。
Int J Mol Sci. 2021 Feb 27;22(5):2369. doi: 10.3390/ijms22052369.
3
The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.多分次放疗后 p53-53BP1 相关的 A549 和 H1299 人肺癌细胞存活展示了对额外急性 X 射线照射的不同反应。
Int J Mol Sci. 2020 May 8;21(9):3342. doi: 10.3390/ijms21093342.
4
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.表达 CD44 的非小细胞肺癌细胞富含干细胞样特性。
PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.
5
CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.CD44通过Wnt/β-连环蛋白-FoxM1- Twist信号通路驱动肺癌干细胞转移,在功能上至关重要。
Mol Carcinog. 2016 Dec;55(12):1962-1973. doi: 10.1002/mc.22443. Epub 2015 Dec 1.
6
CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells.CD133+细胞通过改变人类肺癌细胞中DNA修复基因的调控来促进放射抗性。
Radiother Oncol. 2014 Mar;110(3):538-45. doi: 10.1016/j.radonc.2013.10.040. Epub 2014 Jan 16.
7
Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status.多倍体/多核巨细胞和慢循环癌细胞在人胶质母细胞瘤细胞中对 X 射线照射的反应中的富集,这些细胞在放射抗性和 TP53/PTEN 状态上存在差异。
Int J Mol Sci. 2023 Jan 8;24(2):1228. doi: 10.3390/ijms24021228.
8
IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.白细胞介素-6信号通路促进肺癌CD133 + 干细胞样细胞的DNA修复并防止其在放疗后发生凋亡。
Radiat Oncol. 2015 Nov 14;10:227. doi: 10.1186/s13014-015-0534-1.
9
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.顺铂耐药非小细胞肺癌细胞系的构建及特性分析,其具有干细胞样特征。
PLoS One. 2013;8(1):e54193. doi: 10.1371/journal.pone.0054193. Epub 2013 Jan 17.
10
CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.CD44和CD24不能作为人肺腺癌细胞系A549中的癌症干细胞标志物。
Cell Mol Biol Lett. 2014 Mar;19(1):23-36. doi: 10.2478/s11658-013-0112-1. Epub 2013 Dec 23.

引用本文的文献

1
Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence.靶向癌症干细胞以克服耐药性和肿瘤复发的纳米材料。
Front Oncol. 2025 Jun 6;15:1499283. doi: 10.3389/fonc.2025.1499283. eCollection 2025.
2
Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma.肿瘤坏死因子受体超家族21的缺失诱导肺腺癌对顺铂敏感。
Oncol Res. 2025 Feb 28;33(3):653-663. doi: 10.32604/or.2024.050182. eCollection 2025.
3
Green silver nanoparticles curcumin conjugate induced photodynamic therapy of lung cancer and lung cancer stem cells.

本文引用的文献

1
Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis.肺腺癌中三阴性表达(ALDH1A1-/CD133-/突变型 p53-)的病例预后良好。
Sci Rep. 2022 Jan 27;12(1):1473. doi: 10.1038/s41598-022-05176-0.
2
CD44: A Multifunctional Mediator of Cancer Progression.CD44:癌症进展的多功能介质。
Biomolecules. 2021 Dec 9;11(12):1850. doi: 10.3390/biom11121850.
3
Evaluation of DNA double-strand break repair capacity in human cells: Critical overview of current functional methods.人类细胞中 DNA 双链断裂修复能力的评估:当前功能方法的批判性综述。
绿色银纳米颗粒姜黄素共轭物诱导的肺癌及肺癌干细胞光动力治疗
RSC Adv. 2025 Feb 14;15(7):5020-5041. doi: 10.1039/d4ra06035k. eCollection 2025 Feb 13.
4
Loss of Fascin2 increases susceptibility to cisplatin-induced hearing impairment and cochlear cell apoptosis in mice.Fascin2缺失会增加小鼠对顺铂诱导的听力损伤及耳蜗细胞凋亡的易感性。
J Otol. 2024 Jul;19(3):133-139. doi: 10.1016/j.joto.2024.07.001. Epub 2024 Oct 19.
5
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.去分化过程驱动的表观遗传改变中肺癌干细胞的分子特征。
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
6
TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells.转谷氨酰胺酶2介导的自噬促进非小细胞肺癌干细胞的放射抗性。
Biomedicines. 2024 Sep 30;12(10):2231. doi: 10.3390/biomedicines12102231.
7
Post-translational modifications: The potential ways for killing cancer stem cells.翻译后修饰:杀死癌症干细胞的潜在途径。
Heliyon. 2024 Jul 4;10(14):e34015. doi: 10.1016/j.heliyon.2024.e34015. eCollection 2024 Jul 30.
8
DNMT1/miR-152-3p/SOS1 signaling axis promotes self-renewal and tumor growth of cancer stem-like cells derived from non-small cell lung cancer.DNMT1/miR-152-3p/SOS1 信号轴促进非小细胞肺癌来源的癌症干细胞样细胞的自我更新和肿瘤生长。
Clin Epigenetics. 2024 Apr 15;16(1):55. doi: 10.1186/s13148-024-01663-5.
9
MITF regulates the subcellular location of HIF1α through SUMOylation to promote the invasion and metastasis of daughter cells derived from polyploid giant cancer cells.MITF 通过 SUMOylation 调节 HIF1α 的亚细胞定位,从而促进多倍体巨癌细胞衍生的子细胞的侵袭和转移。
Oncol Rep. 2024 May;51(5). doi: 10.3892/or.2024.8722. Epub 2024 Mar 8.
10
Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis.休眠癌细胞和多倍体巨癌细胞:癌症复发和转移的根源。
Clin Transl Med. 2024 Feb;14(2):e1567. doi: 10.1002/ctm2.1567.
Mutat Res Rev Mutat Res. 2021 Jul-Dec;788:108388. doi: 10.1016/j.mrrev.2021.108388. Epub 2021 Jun 25.
4
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment.CHK1 可保护表达致癌 KRAS 的细胞免受 DNA 损伤,是治疗胰腺癌的靶点。
Cell Rep. 2021 Nov 30;37(9):110060. doi: 10.1016/j.celrep.2021.110060.
5
Recent advances in γH2AX biomarker-based genotoxicity assays: A marker of DNA damage and repair.γH2AX 生物标志物为基础的遗传毒性检测方法的最新进展:DNA 损伤与修复的标志物。
DNA Repair (Amst). 2021 Dec;108:103243. doi: 10.1016/j.dnarep.2021.103243. Epub 2021 Oct 21.
6
When dormancy fuels tumour relapse.休眠促进肿瘤复发。
Commun Biol. 2021 Jun 16;4(1):747. doi: 10.1038/s42003-021-02257-0.
7
IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression.IR存活的非小细胞肺癌细胞表现出与多分割照射方案和p53家族蛋白表达相关的不同分子和细胞反应模式。
Cancers (Basel). 2021 May 28;13(11):2669. doi: 10.3390/cancers13112669.
8
Different Stages of Quiescence, Senescence, and Cell Stress Identified by Molecular Algorithm Based on the Expression of Ki67, RPS6, and Beta-Galactosidase Activity.基于 Ki67、RPS6 和β-半乳糖苷酶活性表达的分子算法鉴定的静止期、衰老期和细胞应激的不同阶段。
Int J Mol Sci. 2021 Mar 18;22(6):3102. doi: 10.3390/ijms22063102.
9
The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.多分割照射存活 NSCLC 细胞的 CD44high 亚群根据其 p53 状态表现出部分 EMT 程序激活和 DNA 损伤反应。
Int J Mol Sci. 2021 Feb 27;22(5):2369. doi: 10.3390/ijms22052369.
10
: an emerging biomarker and potential therapeutic target for cancer.一种新兴的癌症生物标志物和潜在治疗靶点。
Biomark Med. 2021 Apr;15(5):373-384. doi: 10.2217/bmm-2020-0179. Epub 2021 Mar 5.